Huiyuan Wang

Dr. Huiyuan Wang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2024 in Heliyon
Verified
Journal Article
Open access
JXJie Xu
Jie Xu
XCXin-Yi Chen
Xin-Yi Chen
HWHuiyuan Wang
Huiyuan Wang
YSYa-Fei Shang
Ya-Fei Shang
PSPan-Pan Shen
Pan-Pan Shen
YGYu Geng
Yu Geng
Half of the patients with acute large artery occlusion (LAO) have poor outcomes after endovascular treatment (EVT). Early complications such as cerebral edema and symptomatic intracranial hemorrhage (sICH) can lead to early neurological deterioration (END), which correlates with hemodynamics. This study aimed to identify the hemodynamic predictors of END and outcomes in LAO patients after EVT. A total of 76 patients with anterior circulation LAO who underwent EVT and received transcranial Doppler (TCD) monitoring were included. Bilateral middle cerebral artery (MCA) blood flow velocities (BFVs) were measured repeatedly within 1 week. Mean flow velocities (MFV) and MFV index (ipsilateral MFV/contralateral MFV) were calculated. The primary outcome was the incidence of END within 72 h. The secondary outcome was the functional outcome at 90 days-a good outcome was defined as a modified Rankin scale (mRS) score of 0-2, while a poor outcome was defined as an mRS score of 3-6. A total of 13 patients (17.1 %) experienced END within 72 h, including 5 (38.5 %) with cerebral edema, 5 (38.5 %) with sICH, and 3 (23.0 %) with infarct progression. Multivariable logistic regression analysis showed that a higher 24 h MFV index was independently associated with END (aOR 10.5; 95 % CI 2.28-48.30, p = 0.003) and a poor 90-day outcome (aOR 5.10; 95 % CI 1.38-18.78, p = 0.014). The area under the receiver operating characteristic (ROC) curve (AUC) of the 24 h MFV index for predicting END was 0.807 (95 % CI 0.700-0.915, p = 0.0005), the sensitivity was 84.6 %, and the specificity was 66.7 %. At the 1-week TCD follow-up, patients who had poor 90-day outcomes showed significantly higher 1-week iMFV [73.5 (58.4-99.0) vs. 57.7 (45.3-76.3), p = 0.004] and MFV index [1.24 (0.98-1.57) vs.1.0 (0.87-1.15) p = 0.007]. A persistent high MFV index (PHMI) was independently associated with a poor outcome (aOR 7.77, 95 % CI 1.81-33.3, p = 0.006). TCD monitoring within 24 h after EVT in LAO patients can help predict END, while dynamic follow-up within 1 week is valuable in predicting clinical outcomes.

12 November 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
HWHuiyuan Wang
Huiyuan Wang
PSPanpan Shen
Panpan Shen
XYXinyue Yu
Xinyue Yu
YSYafei Shang
Yafei Shang
JXJie Xu
Jie Xu
YGYu Geng
Yu Geng
Objective: To explore the relationship between asymmetric deep cerebral venous (ADCV) filling and poor outcomes after endovascular treatment (EVT) in patients with acute basilar artery occlusion (ABAO).Methods: ABAO patients were selected from a prospectively collected data at our center. The DCV filling was evaluated using computed tomography perfusion (CTP)‐derived reconstructed 4D‐DSA or mean venous map. ADCV filling was defined as the internal cerebral vein (ICV), thalamostriate vein (TSV), or basal vein of Rosenthal (BVR) presence of ipsilateral filling defects or delayed opacification compared to the contralateral side. Poor prognosis was defined as a modified Rankin scale score >3 at the 90‐day follow‐up.Results: A total of 90 patients were enrolled in the study, with a median Glasgow Coma Scale of 6, 46 (51.1%) showed ADCV filling, 59 (65.6%) had a poor prognosis, and 27 (30.7%) had malignant cerebellar edema (MCE). Multivariate adjusted analysis revealed significant associations between asymmetric TSV and poor prognosis (odds ratio, 9.091, p = 0.006); asymmetric BVR (OR, 9.232, p = 0.001) and asymmetric ICV (OR, 4.028, p = 0.041) were significantly associated with MCE.Conclusion: Preoperative ADCV filling is an independent influencing factor for the poor outcome after EVT in ABAO patients.

24 October 2025 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
WGWenting Guo
Wenting Guo
DLDu Liping
Du Liping
YYYang Yi
Yang Yi
HJHu Jin
Hu Jin
YBYe Bijun
Ye Bijun
STShi Tianming
Shi Tianming
Objective: This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods: In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation ( n = 301) and validation ( n = 205) cohorts. Multivariable logistic regression was performed to determine independent predictors of central VS. These predictors were assigned weights to construct the SAV 3 E score. The performance of the SAV 3 E was assessed using the area under the curve (AUC), calibration, and decision curve analysis (DCA) and compared with that of the TriAGe+ and STANDING models. Results: The SAV 3 E score incorporated five predictors: absence of vestibular vagal symptoms (OR, 0.233; 95% CI, 0.084–0.648; p = 0.005), prior stroke (OR, 15.204; 95% CI, 4.455–51.884; p < 0.001), ABCD 2 score of 4–7 (OR, 1.903; 95% CI, 1.206–3.004; p = 0.006), central video oculography nystagmus (OR, 38.377; 95% CI, 8.631–170.644; p < 0.001), and positive video head impulse test (OR, 0.078; 95% CI, 0.033–0.188; p < 0.001). It displayed good discriminative performance with AUCs 0.910 and 0.886 in the derivation and validation cohorts, respectively. It outperformed TriAGe+ (AUC: 0.706) and STANDING (AUC: 0.779) models. Furthermore, calibration analysis revealed good model fit across cohorts (Hosmer‐Lemeshow test results: derivation cohort, p = 0.899; validation cohort, p = 0.789). DCA confirmed good clinical utility across a wide range of probability thresholds (derivation cohort: 0.01–0.86, validation cohort: 0.01–1.00). Conclusion: The SAV 3 E score is a validated tool aimed at differentiating central versus peripheral VS, with the potential to improve diagnostic accuracy for urgent etiologies such as stroke.